Glycologix, Inc.
New Form D on file · 2025-12-29 · the record
Before you sell to, join or invest in Glycologix, Inc.
MentionFox check on Glycologix, Inc.: only 1 source on file so far (checked 9 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/glycologix-inc-form-d-25000002
Check Glycologix, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Glycologix, Inc. filed a Form D with the Securities and Exchange Commission on 2025-12-29.
Glycologix, Inc. filed a Form D notice of an exempt securities offering with the SEC on December 29, 2025. The filing reports $800K sold. Its industry group is Other Technology. It names Daniel Deardorf (Executive Officer, Director), George Adaniya (Director), Michael Chester (Director) (SEC Form D, December 29, 2025).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Glycologix, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-12-29 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Glycologix, Inc.
Free to see. No signup.
More on the people and the money behind Glycologix, Inc., from the filings we hold.
Other Technology raises by companies based in Massachusetts, filed in December 2025, largest first.
Get an email when Glycologix, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Glycologix, Inc. raises, hires or launches. No email unless you switch it on.
Watch Glycologix, Inc. →Get the full cited report on Glycologix, Inc.
What the filing shows about Glycologix, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Glycologix, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Glycologix, Inc.'s address as 100 Cummings Center, Suite 451C, Beverly, MA 01915.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Glycologix, Inc. is a registered filer with the SEC (CIK 1903671) and has filed since 2023-05-23. 3 filings are on record, the latest on 2025-12-29.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Glycologix, Inc.'s Form D of 2025-12-29 names Daniel Deardorf, George Adaniya, Michael Chester and 2 more as its officers, directors or promoters.
Its new offerings report $3.40M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 3862 filings in Other Technology, totalled by week. The dot is this raise, $800K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Daniel Deardorf is named as Executive Officer and Director on the Form D that Glycologix, Inc. filed with the SEC on 29 December 2025, one of 5 people that filing names.
George Adaniya is named as Director on the Form D that Glycologix, Inc. filed with the SEC on 29 December 2025, one of 5 people that filing names.
Michael Chester is named as Director on the Form D that Glycologix, Inc. filed with the SEC on 29 December 2025, one of 5 people that filing names.
Martha Farmer is named as Director on the Form D that Glycologix, Inc. filed with the SEC on 29 December 2025, one of 5 people that filing names.
Michael Marsh is named as Director on the Form D that Glycologix, Inc. filed with the SEC on 29 December 2025, one of 5 people that filing names.
5 people named on the filing — 1 holding an executive role and 4 as directors only.
Named as of the 2025-12-29 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Glycologix, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Glycologix, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Glycologix, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Glycologix, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Glycologix, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Glycologix, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/glycologix-inc-form-d-25000002